Professor in Surgery
ALICE Program
Duke Research and Discovery @RTP
Third Year Mentor - Microbiology, Infectious Diseases and Immunology Study Program (MIDIP)
Campus mail:
Box 103020 DUMC, Durham, NC 27710
Phone:
(919) 681-5598
Research in the Tomaras Laboratory in the Duke Human Vaccine Institute and Departments of Surgery, Immunology, and Molecular Genetics and Microbiology at Duke University Medical Center, focuses on the identification of immune correlates of protection for preventative vaccines and identification of the mechanisms responsible for potent inhibition of human pathogens.
Education and Training
- SUNY Upstate Medical University, Ph.D. 1998
- Duke University, Postdoctoral Fellowship, Center For Aids Research, Department Of Surgery
Selected Grants and Awards
- Transplant Infectious Diseases Interdisciplinary Research Training Grant
- Quantitative Methods for HIV/AIDS Research
- Duke Resident Physician-Scientist Program- NIAID
- Functional profile to HIV vaccine elicited antibodies in infants
- Bioinformatics and Computational Biology Training Program
- Bridging Antibody Fc-mediated Antiviral Functions Across Humans and Non-human Primates
- Interdisciplinary Research Training Program in AIDS
- Identifying key determinants of IgG transplacental transfer from HIV-infected mothers to their fetus
- PRO HIV-013 Humoral Immune Response
- Basic Immunology Training Program
- Viral Oncology Training Grant
- Harnessing Mucin-IgG Interactions to Enhance HIV Vaccine Function
- Nonhuman Primate Core
- HIV Research for Prevention 2018: Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P)
- HVTN Laboratory Center: HVTN 117
- HVTN Laboratory Center: HVTN 118
- HIV Vaccine Trials Network: LC P5 PF
- HIV Vaccine Trials Network: LC Phase 1 PF
- HVTN - A004
- HVTN 704 Protocol
- LC: HIV Vaccine Trials Network
- Humoral and cellular immunity during acute HIV-1
- Focus 2: Clearance of HIV Antigen-Positive Cells
- Nonhuman Primate Core-Option 6
- Statistical methods for HIV-1 immune correlates studies
- The duality of vaccine elicited HIV specific-IgA antibodies: Providing protection or diminishing protection
- HVTN 117
- Early Infection Response
- Animal Models of Infectious Diseases Part A
- Statistical methods for HIV-1 immune correlates studies
- HIV Vaccine Trials Network: LC P5 PF
- HVTN 505 Protocol
- HVTN LC: Virion Capture
- LC: HIV Vaccine Trials Network: Phase 1 PF
- McElrath Objective 3-Evaluate potential mucosal quality indicators
- Vaccine-induced HIV antibody responses in infants
- Harnessing Antibody-Mucus Interaction to Prevent HIV Transmission
- Education - Training
- HIV-1 Gene Suppression by CD8+ T Cells
- Testing the ability of antibody-mucin interactions to provide vaccine function
- Epigenetic Control of the CD8+ T-cell Response to HIV
- McElrath Objective 3-Evaluate potential mucosal quality indicators
- AIDS International Training and Research Program
- Non-human Primate Binding Antibody Evaluation
- Large Scale Antibody and TCell Epitope Discovery
- Elucidation of the Mechanisms of CD8+ T Cell Noncytolytic Antiviral Response
- Central Laboratory for the HIV Vaccines Trial Network
- NCRR FACSAria Cell Sorter